Post by imona on Dec 20, 2023 3:50:28 GMT
The report also discusses in detail the recent mergers and acquisitions, joint ventures, collaborations, product launches and brand promotions, agreements, corporate and government deals, and partnerships, among others. The report also sheds light on the recent technological developments and product advancements in the Predictive Biomarkers Market. The competitive landscape of the report has been formulated by considering all the vital parameters such as company profiling, market share, recent developments and advancements, gross margins, product portfolio, revenue generation, financial standing, market position, and expansion plans.
The global predictive biomarkers market is expected to register a revenue CAGR during the forecast period. Increase in number of clinical trials is a key factor driving market revenue growth during the forecast period. In addition, developments and advancements in this field are expanding. Approximately, 427,086 clinical studies are currently under trial globally. Predictive biomarkers are also utilized to identify patients who will benefit from adjuvant radio- and or chemotherapy. Predictive biomarkers can help with patient care decisions like choosing between different interventions or figuring out which patients would benefit from a particular treatment. For instance, Kirsten Ras (KRAS) is a frequently mutated oncogene in colorectal cancer and a predictive biomarker for Epidermal Growth Factor (anti-EGFR) monoclonal antibody therapy resistance. According to MD Anderson Cancer, KRAS mutations are among the most prevalent gene mutations associated with cancer, found in about 25% of malignancies.
Increasing cases of cardiovascular disorders and others is a major factor contributing to revenue growth of the market. Major companies are focusing on product launches for new companion diagnostics for different cancers. For instance, on 10 October 2020, F. Hoffmann-La Roche Ltd stated that the Cobas EGFR Mutation Test v2 has received approval from the U.S. Food and Drug Administration (FDA) for expanded claims as a Companion Diagnostic (CDx) for a wider range of medicines in the treatment of Non-Small Cell Lung Cancer (NSCLC). According to the approved therapeutic product labeling, this claim expansion enables the test to be used as a CDx for all five Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) medicines currently approved by the FDA that target EGFR mutations L858R and Exon 19 deletions.
Get Free Exclusive Sample PDF Copy @ www.emergenresearch.com/request-sample/261
Key Highlights of the Report:
The report offers a comprehensive overview of the Predictive Biomarkers Market along with historical analysis and an accurate forecast estimation
The report covers extensive analysis of the Predictive Biomarkers Market segmentation based on product types, applications, end-user industries, and key regions
Extensive coverage of the competitive landscape along with product portfolio, production and manufacturing capacity, and strategic alliances and business expansion plans
In-depth analysis of the market drivers, restraints, limitations, risks, threats, and growth prospects in the market
Strategic recommendations to the established players and new entrants to help them gain a robust footing in the industry
Predictive Biomarkers Market: Dynamics
The Global Predictive Biomarkers Market is predominantly driven by the increase in cancer incidences across the globe, augmenting the applications of biomarkers in cancer diagnosis. Moreover, augmented investments and funding for the advancements for Research and Development in pharmaceutical companies and biotechnology companies by government and non-government bodies are further driving the market's growth.
Major Players/Manufacturers profiled in the report are:
Roche Diagnostic Limited
Siemens Healthcare
Abbott Laboratories
Qiagen
Johnson and Johnson
E. Healthcare
PerkinElmer, Inc.
Merck KGaA
Thermo Fisher Scientific, Inc.
Affymetrix, Inc.
Request a discount on the report @ www.emergenresearch.com/request-discount/261
Emergen Research has segmented the global Predictive Biomarkers based on product, Application and region:
Product Type:
Cancer
Neurological Disorders
Immunological Disorders
Cardiovascular Disorders
Application:
CROs
Biopharmaceutical Companies
Academic and Research Institutes
Diagnostic Centers
Key Benefits of the Report:
Comprehensive analysis of the competitive scenario and its changing dynamics
Analytical data with detailed SWOT analysis and Porter’s Five Forces analysis
In-depth 8 Year analysis of the Global predictive biomarkers Market
Critical assessment of the key market segments
Comprehensive analysis of the drivers, restraints, trends, and opportunities
Detailed regional analysis and extensive company profiling
Extensive assessment of current and emerging trends of the market
Click here to Buy Now @ www.emergenresearch.com/select-license/261
Thank you for reading our report. The report can be customized according to the requirements of the clients. Please get in touch with and our team will ensure the customization is as per your needs.
Read similar reports by Emergen Research:
hemodynamic monitoring devices market
www.emergenresearch.com/industry-report/hemodynamic-monitoring-devices-market
automotive data monetization market
www.emergenresearch.com/industry-report/automotive-data-monetization-market
hybrid operating room market
www.emergenresearch.com/industry-report/hybrid-operating-room-market
technical insulation market
www.emergenresearch.com/industry-report/technical-insulation-market
single use/disposable endoscopy market
www.emergenresearch.com/industry-report/single-use-disposable-endoscopy-market
soil testing equipment market
www.emergenresearch.com/industry-report/soil-testing-equipment-market
nanorobotics market
www.emergenresearch.com/industry-report/nanorobotics-market
mobile phlebotomy services market
www.emergenresearch.com/industry-report/mobile-phlebotomy-services-market
operational database management market
www.emergenresearch.com/industry-report/operational-database-management-market
ai-based clinical trials solution provider market
www.emergenresearch.com/industry-report/ai-based-clinical-trials-solution-provider-market
digital phase shifters market
www.emergenresearch.com/industry-report/digital-phase-shifters-market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Latest Reports: video surveillance market | hair styling market
Trending Titles: license management market | smart transportation market
The global predictive biomarkers market is expected to register a revenue CAGR during the forecast period. Increase in number of clinical trials is a key factor driving market revenue growth during the forecast period. In addition, developments and advancements in this field are expanding. Approximately, 427,086 clinical studies are currently under trial globally. Predictive biomarkers are also utilized to identify patients who will benefit from adjuvant radio- and or chemotherapy. Predictive biomarkers can help with patient care decisions like choosing between different interventions or figuring out which patients would benefit from a particular treatment. For instance, Kirsten Ras (KRAS) is a frequently mutated oncogene in colorectal cancer and a predictive biomarker for Epidermal Growth Factor (anti-EGFR) monoclonal antibody therapy resistance. According to MD Anderson Cancer, KRAS mutations are among the most prevalent gene mutations associated with cancer, found in about 25% of malignancies.
Increasing cases of cardiovascular disorders and others is a major factor contributing to revenue growth of the market. Major companies are focusing on product launches for new companion diagnostics for different cancers. For instance, on 10 October 2020, F. Hoffmann-La Roche Ltd stated that the Cobas EGFR Mutation Test v2 has received approval from the U.S. Food and Drug Administration (FDA) for expanded claims as a Companion Diagnostic (CDx) for a wider range of medicines in the treatment of Non-Small Cell Lung Cancer (NSCLC). According to the approved therapeutic product labeling, this claim expansion enables the test to be used as a CDx for all five Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) medicines currently approved by the FDA that target EGFR mutations L858R and Exon 19 deletions.
Get Free Exclusive Sample PDF Copy @ www.emergenresearch.com/request-sample/261
Key Highlights of the Report:
The report offers a comprehensive overview of the Predictive Biomarkers Market along with historical analysis and an accurate forecast estimation
The report covers extensive analysis of the Predictive Biomarkers Market segmentation based on product types, applications, end-user industries, and key regions
Extensive coverage of the competitive landscape along with product portfolio, production and manufacturing capacity, and strategic alliances and business expansion plans
In-depth analysis of the market drivers, restraints, limitations, risks, threats, and growth prospects in the market
Strategic recommendations to the established players and new entrants to help them gain a robust footing in the industry
Predictive Biomarkers Market: Dynamics
The Global Predictive Biomarkers Market is predominantly driven by the increase in cancer incidences across the globe, augmenting the applications of biomarkers in cancer diagnosis. Moreover, augmented investments and funding for the advancements for Research and Development in pharmaceutical companies and biotechnology companies by government and non-government bodies are further driving the market's growth.
Major Players/Manufacturers profiled in the report are:
Roche Diagnostic Limited
Siemens Healthcare
Abbott Laboratories
Qiagen
Johnson and Johnson
E. Healthcare
PerkinElmer, Inc.
Merck KGaA
Thermo Fisher Scientific, Inc.
Affymetrix, Inc.
Request a discount on the report @ www.emergenresearch.com/request-discount/261
Emergen Research has segmented the global Predictive Biomarkers based on product, Application and region:
Product Type:
Cancer
Neurological Disorders
Immunological Disorders
Cardiovascular Disorders
Application:
CROs
Biopharmaceutical Companies
Academic and Research Institutes
Diagnostic Centers
Key Benefits of the Report:
Comprehensive analysis of the competitive scenario and its changing dynamics
Analytical data with detailed SWOT analysis and Porter’s Five Forces analysis
In-depth 8 Year analysis of the Global predictive biomarkers Market
Critical assessment of the key market segments
Comprehensive analysis of the drivers, restraints, trends, and opportunities
Detailed regional analysis and extensive company profiling
Extensive assessment of current and emerging trends of the market
Click here to Buy Now @ www.emergenresearch.com/select-license/261
Thank you for reading our report. The report can be customized according to the requirements of the clients. Please get in touch with and our team will ensure the customization is as per your needs.
Read similar reports by Emergen Research:
hemodynamic monitoring devices market
www.emergenresearch.com/industry-report/hemodynamic-monitoring-devices-market
automotive data monetization market
www.emergenresearch.com/industry-report/automotive-data-monetization-market
hybrid operating room market
www.emergenresearch.com/industry-report/hybrid-operating-room-market
technical insulation market
www.emergenresearch.com/industry-report/technical-insulation-market
single use/disposable endoscopy market
www.emergenresearch.com/industry-report/single-use-disposable-endoscopy-market
soil testing equipment market
www.emergenresearch.com/industry-report/soil-testing-equipment-market
nanorobotics market
www.emergenresearch.com/industry-report/nanorobotics-market
mobile phlebotomy services market
www.emergenresearch.com/industry-report/mobile-phlebotomy-services-market
operational database management market
www.emergenresearch.com/industry-report/operational-database-management-market
ai-based clinical trials solution provider market
www.emergenresearch.com/industry-report/ai-based-clinical-trials-solution-provider-market
digital phase shifters market
www.emergenresearch.com/industry-report/digital-phase-shifters-market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Latest Reports: video surveillance market | hair styling market
Trending Titles: license management market | smart transportation market